For Immediate Release
June 29, 2005
GlaxoSmithKline Investor Wachovia Securities Attacked by ALF; Investors in HLS Customers Continue to be Targeted
Long Island, NY: In an anonymous communique received yesterday, the Animal Liberation Front (ALF) claims to have attacked GlaxoSmithKline(GSK) investor Wachovia Securities as retaliation for GSK’s continued support of Huntingdon Life Sciences(HLS). HLS is a laboratory notorious for animal cruelty violations, as exposed in five different undercover investigations; they admit to killing 500 animals per day testing such products as oven cleaners and pesticides for their customers.
According to the communiqué:
“These actions took place because of GlaxoSmithKline’s continued support of Huntingdon Life Sciences. Glaxo has shown the activist community that it does not care about the 180,000 animals that die at HLS each year. Glaxo has shown that it does not care about the welfare of children dying in the third world. Glaxo has shown that it will continue to sell drugs that kill American youth and destroy families.
Wachovia Corp is one of the largest institutional holders of Glaxo stock with outstanding GSK Shares = +11,664,178, valued at ~ $567,345,617. Wachovia has also made the mistake of welcoming Glaxo VP Robert Ingram to their board of directors.”
A spokesperson for Stop Huntingdon Animal Cruelty (SHAC) stated “While we do not condone breaking the law, it is clear the passion of some animal defenders will hold those accountable that make animal torture a reality in places like HLS”. For more information on the SHAC campaign against HLS cruelty, visit www.shacamerica.net.